Sorry, you need to enable JavaScript to visit this website.

XALACOM (latanoprost and timolol ophthalmic solution (as timolol maleate) Dosage Forms, Composition And Packaging

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Dosage Forms, Composition And Packaging

XALACOM (latanoprost and timolol maleate) is a sterile, isotonic, buffered, clear and colorless aqueous solution. One drop contains approximately 1.5 mcg of latanoprost and 150 mcg of timolol.

XALACOM is intended for topical administration on the eye.

XALACOM is supplied in a 5 mL plastic ophthalmic dispenser bottle with a dropper tip, screw cap and tamper proof polyethylene overcap.

Each bottle contains 2.5 mL of XALACOM corresponding to approximately 80 drops of solution.

XALACOM is supplied as a sterile, isotonic, buffered, clear and colorless aqueous solution with a pH of approximately 6.0 and an osmolality of approximately 290 mOsmol/kg. Each mL contains 50 micrograms (mcg) of latanoprost and 5 mg of timolol (6.83 mg timolol maleate).

Non-medicinal ingredients: sodium chloride, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous, and water for injection. Benzalkonium chloride 0.02% is added as a preservative. If required, the pH of the solution is adjusted with hydrochloric acid and/or sodium hydroxide.


Control #: 237590
May 7, 2020

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111